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Policy and Régulations for 
Registration of Microbial Organisms 
Registration of Biological Pesticides 
in Sweden and the EU 
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INTRODUCTION 
The fact that a plant protection product 
has a biological origin does not neces-
sarily mean that it is harmless. This is 
the main reason why, in Sweden, bio-
logical pesticides may be used and 
offered for sale only if approved by the 
National Chemicals Inspectorate (Keml). 
For the purposes of the 1991 Act on 
preliminary examination of biopesti-
cides, the term "biological pesticide" 
refers to microorganisms, viruses, nem-
atodes, insectsorArachnida,developed 
particularly to prevent or counteract 
sanitary nuisance or damage on prop-
erty from animais, plants, microorgan-
isms or viruses. Act (1992:605) Hère, 
'developed' meanscultivation of organ-
ism, organism reproduction, harvest 
and concentration, addition of other 
components, and packaging. 
NATIONAL LEGISLATION 
The National Chemicals Inspectorate 
examines applications for approval of 
biological pesticides. The Chemicals 
Inspectorates régulations (KIFS 1994:4) 
on biological pesticides, annexed, con-
tain provisions for the application. Ac-
cording to Section 3, an application for 
approval of a biological pesticide must 
contain the information needed for a 
satisfactory assessment to be made as 
to whether the préparation is accept-
able from the standpoints of human 
health and the environment and if it is 
needed for pest control purposes. Ap-
plication forms are provided by the 
Inspectorate, along with a guide in two 
versions (one for microorganisms in-
cluding viruses and one for nematodes, 
insects and Arachnids) to the comple-
tion of the form. The applicant himself 
must décide what information is rele-
vant and submit it. Where there is un-
certainty, Keml may request supplemen-
tary documentation. 
EU-DIRECTIVE(S) 
The Council directive on plant protec-
tion products (91/414/EEC) is in use in 
Sweden since 1995, when Sweden be-
came a Member State. The directive 
includes as active organisms, microor-
ganisms and viruses. So far, draft data 
requirements for microbiais (Annex II 
and III, working documents 4992/VI/95 
- rev 2 and 4993/VI/95 - rev.2) hâve been 
established. However, décision making 
criteria (Uniform Principles) only exist 
for chemical active substances. 
Additional directives which bare im-
pact on the régulation on biological pes-
ticides are the biocide directive 98/8/EC, 
directives 90/219/EEC and 90/220/EEC, 
regulating the contained use and delib-
erate release of genetically modified or-
ganisms and directive 90/679/EEC with 
the aim to protect workers against risks 
to their health and safety arising from 
exposure to biological agents at work. 
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THE EVALUATION 
PROCEDURE 
The évaluation of microorganisms as 
pesticides is in a developmental phase. 
We repeatedly need to ask ourselves: 
are we on the right track or are we just 
following the deep and familiar tracks 
aiready set by expérience from dealing 
with chemicals? 
The first step in evaluating would be 
to identify the organism and aiready 
the name will give useful information. 
Is the organism known to the scientific 
society or is it "new"? 
The second step is to establish the 
organisms properties, from the litera-
ture if available or from tests and stud-
ies if appropiate. Thèse include in terms 
of description; the organisms biology, 
mode of action, life cycle, host specific-
ity, impact on non-targets, pathogenic-
ity, known opportunism, médical re-
ports, toxin production, efficacy etc. 
From the properties it is possible to 
describe what kind of a hazard the or-
ganism potentially may possess. Re-
garding the human health aspects also 
the lack of information is important. A 
commonly occurring bacterium or fun-
gus not reported in connection to any 
disease can probably be regarded as 
non-pathogenic. 
The risk assessment step include fac-
tors in connection to the use and who 
are not directly dépendent on the or-
ganism in itself. Such factors relate to 
exposure, natural occurrence, applica-
tion method, formulation, environmen-
tal conditions where the product is to 
be used, détection methods, residues, 
background level, post release control, 
potential resting stages. 
When evaluating the risk the expo-
sure situation is important. Even if the 
organism is naturally and commonly 
occurring, the exposure, while using it 
as a pesticide can be expected to be 
much higherthan normally. The meth-
od of application as well as the type of 
formulation can often be of crucial 
importance and evidently a way to re-
duce potential risk for workers. 
Available identification methods for 
the purposes of follow up on residues 
and for post release control are a nec-
essary tool in assessing the risk. It is 
also important to consider methods for 
identification of possible resting stag-
es. 
ACCEPTANCE CRITERIA 
In the abscense of spécifie décision 
making criteria at Community level, 
décisions will hâve to be made on a 
case by case basis. But some gênerai 
criteria are in my opinion ready to be 
drawn up. Biological pesticides that are 
known to the scientific society, com-
monly occurring in the area where to be 
used, of natural origin and repeatedly 
encountered by humans, not reported 
to cause human or non-target disease, 
can be detected for post-release control 
and for which the mode of action is 
known could be approved after thor-
ough judgement by experts. A precau-
tionary approach will hâve to be reflect-
ed in the décisions and conditions until 
more expérience is gained in practice in 
the field and in risk management. 
Biological pesticides, through their 
mode of action, are often very target-
specific and should therefore be in-
herently less hazardous to non-target 
organisms. This advantageous charac-
teristic also has the négative effect to 
narrow the market for thèse products, 
which in turn puts increasing pressure 
on regulatory authorities as to not de-
mand extra information not needed for 
appropiate risk assessment. Biological 
pesticides are an important alternative 
to chemicals and may become useful in 
comparative assessment and the phas-
ing out of problematic chemicals. 
CURRENT SITUATION 
Since January -95, 45 biological pesti-
cides (products) hâve been authorized 
in Sweden with 17 différent species, 
mainly insects and predatory mites, as 
active organisms. A few applications 
hâve been rejected due to technical 
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reasons (lack of data etc). Restrictions 
hâve been made in the use area in some 
cases and one species (insect) has been 
denied approval after risk assessment. 
Based on this expérience a document 
on the risk assessment procédure fo-
cusing on the risks connected with the 
introduction of foreign macroorganisms 
has been written. Expérimental permits 
hâve been issued for the development 
of new products. Aerial application of 
Bt has been approved on two occas-
sions for two severely infested forest 
areas. 
There are presently additional 18 
products that are being applied for in 
Sweden, consisting of 7 différent mi-
cro-organisms, 4 nematodes and 1 in-
sect species. Many of thèse products 
were already in use when the législa-
tion came into force and were therefore 
granted a temporary exemption from 
the demand on registration while Keml 
is handling there application so not to 
eliminate the market and use. 
As Rapporteur Member State Swe-
den has prepared a monograph on a 
"EU-new" organism, Pseudomonas 
chlororaphis MA 342, according to the 
91/414/EEC. The monograph and pro-
posed décision for inclusion on Annex 
I hâve been discussed during summer 
and will continue to be discussed dur-
ing autumn of -98 in various expert and 
regulatory décision meetings at Com-
munity level. Two other monographs 
(prepared by Belgium and France) are 
also being discussed and thèse three 
together are the first microorganisms 
in plant protection products to be han-
dled and decided upon within the EU-
system. Keml has granted the product 
Cedomon containing P. chlororaphisMA 
342 a provîsional authorization while 
waiting for acceptance on inclusion in 
Annex I of directive 91/414/EEC. 
The National Chemicals Inspectorate 
has been contracted by the Commis-
sion (DG VI) to organize a workshop on 
the scientific basis for risk assessment 
of microbiological plant protection prod-
ucts and to rewrite the available docu-
mentation requirements according to 
the outcome of the workshop. The 
workshop will be held in Stockholm, 
Sweden, October 26-28 1998. 
EXPERIENCE GAINED 
Both authorities and notifiers need a 
better knowledge aboutthe organisms. 
A complicating factor is that the data 
requirements are too influenced by the 
requirements for chemicals. Many of 
the tests and studies recommended are 
measuring only toxicological endpoints 
and will thus not give overall useful 
results. Remaining questions can be 
difficult to answer by a traditional ap-
proach of further testing. More basic 
research in (micro-)biology and ecolo-
gy is needed to ensure a better under-
standing of what the potential effects of 
the large scale release of microbiais into 
the environment could entail. 
Information needed for risk assess-
ment is sometimes available but diffi-
cult to reach. With the fast develop-
ment of products out of new research 
discoveries, conflicts seem to arise 
between on the one hand scientists 
wanting to publish their results and on 
the other hand notifiers wanting to use 
them for regulatory purposes. 
Statistics on sold amounts of pesti-
cides in Sweden is annually being pub-
lished by Keml. Biological pesticides 
were for the first time represented in 
their own category in the account for -
97. The interest for thèse products is 
large, especially in green house pro-
duction, and is expected to increase 
further as more products are becoming 
available. There is a great potential of 
"know-how" and interest within the line 
of growers that must not be forgotten 
in the search for reliable information. 
FUTURE NEEDS 
Major resources are being put in to 
research to find "new" organisms and 
develop new products. Product devel-
opment and research are closely linked 
and focused towards new applications 
and markets. The risk management 
enforced by the preapproval System has 
to meet thèse new situations on the 
grounds on scientific documentation 
provided by the notifier and scientific 
community. In short; there has to be 
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more microbiology in the authorisation 
procédure. 
We need to define "critical endpoints" 
to which the data required aim to cor-
respond. By identifying thèse end-
points, priorities can be set for the 
development and establishment of in-
ternational guidelines and protocols for 
testing, where needed. They will also 
be useful in defining mutual acceptance 
criteria. 
I will end as l've been asked by pos-
ing a few questions to scientists, regu-
lators and the OECD; 
How far in détail is it appropiate to 
demand information on the identity of 
an organism? (How well does the spe-
cies concept apply to différent microbi-
ais?) 
What can be considered naturally 
occurring; same species but différent 
strains, is that ok? 
I. Ecological effects on a longer time 
scale - is there a problem? 
II. How can we translate gênerai knowl-
edge/ecology of the organism to 
"critical endpoints"? 
III.Exposure models applicable for mi-
crobiais - a way to go? 
Species specificity and animal mod-
els for infectivity and pathogenicity -
how do we interprate the results? 
What health problems can be fore-
seen? 
IV.Secondary metabolites and the need 
for residue data - a matter of amounts 
detected? 
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